| Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society … LC McDonald, DN Gerding, S Johnson, JS Bakken, KC Carroll, SE Coffin, ... Clinical infectious diseases 66 (7), e1-e48, 2018 | 3312 | 2018 |
| Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study KW Garey, M Rege, MP Pai, DE Mingo, KJ Suda, RS Turpin, DT Bearden Clinical infectious diseases 43 (1), 25-31, 2006 | 1443 | 2006 |
| Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on … S Johnson, V Lavergne, AM Skinner, AJ Gonzales-Luna, KW Garey, ... Clinical infectious diseases 73 (5), e1029-e1044, 2021 | 628 | 2021 |
| Meta-analysis to assess risk factors for recurrent Clostridium difficile infection KW Garey, S Sethi, Y Yadav, HL DuPont Journal of Hospital infection 70 (4), 298-304, 2008 | 485 | 2008 |
| Collection and analysis of exhaled breath condensate in humans GM Mutlu, KW Garey, RA Robbins, LH Danziger, I Rubinstein American journal of respiratory and critical care medicine 164 (5), 731-737, 2001 | 472 | 2001 |
| T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial E Mylonakis, CJ Clancy, L Ostrosky-Zeichner, KW Garey, GJ Alangaden, ... Clinical Infectious Diseases 60 (6), 892-899, 2015 | 470 | 2015 |
| Economic healthcare costs of Clostridium difficile infection: a systematic review SS Ghantoji, K Sail, DR Lairson, HL DuPont, KW Garey Journal of Hospital Infection 74 (4), 309-318, 2010 | 375 | 2010 |
| Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa VH Tam, KT Chang, K Abdelraouf, CG Brioso, M Ameka, LA McCaskey, ... Antimicrobial agents and chemotherapy 54 (3), 1160-1164, 2010 | 232 | 2010 |
| Markers of inflammation in exhaled breath condensate of young healthy smokers KW Garey, MM Neuhauser, RA Robbins, LH Danziger, I Rubinstein Chest 125 (1), 22-26, 2004 | 230 | 2004 |
| Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes VH Tam, CA Rogers, KT Chang, JS Weston, JP Caeiro, KW Garey Antimicrobial agents and chemotherapy 54 (9), 3717-3722, 2010 | 217 | 2010 |
| Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the … GV Doern, KC Carroll, DJ Diekema, KW Garey, ME Rupp, MP Weinstein, ... Clinical microbiology reviews 33 (1), 10.1128/cmr. 00009-19, 2019 | 204 | 2019 |
| A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection KW Garey, SS Ghantoji, DN Shah, M Habib, V Arora, ZD Jiang, ... Journal of antimicrobial chemotherapy 66 (12), 2850-2855, 2011 | 203 | 2011 |
| FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia ND Beyda, J John, A Kilic, MJ Alam, TM Lasco, KW Garey Clinical infectious diseases 59 (6), 819-825, 2014 | 189 | 2014 |
| Bifidobacterium dentium fortifies the intestinal mucus layer via autophagy and calcium signaling pathways MA Engevik, B Luk, AL Chang-Graham, A Hall, B Herrmann, W Ruan, ... MBio 10 (3), 10.1128/mbio. 01087-19, 2019 | 186 | 2019 |
| Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia MP Pai, RS Turpin, KW Garey Antimicrobial agents and chemotherapy 51 (1), 35-39, 2007 | 185 | 2007 |
| Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections KW Garey, T Dao, H Chen, P Amrutkar, N Kumar, M Reiter, LO Gentry Journal of Antimicrobial Chemotherapy 58 (3), 645-650, 2006 | 160 | 2006 |
| Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel CJ Clancy, PG Pappas, J Vazquez, MA Judson, DP Kontoyiannis, ... Clinical Infectious Diseases 66 (11), 1678-1686, 2018 | 158 | 2018 |
| Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections L Gerard, KW Garey, HL DuPont Expert review of anti-infective therapy 3 (2), 201-211, 2005 | 142 | 2005 |
| Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches ND Beyda, RE Lewis, KW Garey Annals of Pharmacotherapy 46 (7-8), 1086-1096, 2012 | 136 | 2012 |
| Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity H Yu, K Chen, Y Sun, M Carter, KW Garey, TC Savidge, S Devaraj, ... Clinical and Vaccine Immunology 24 (8), e00037-17, 2017 | 133 | 2017 |
M. Jahangir Alam, PhDAssistant Professor-ONE HEALTH Microbiology, University of Houston College of PharmacyVerified email at uh.edu
